Abgenix, Inc.
Biotech company reports loss of $0.60 per share
Published in Health Business Week, March 26th, 2004
For the quarter ended December 31, 2003, the company reported a net loss of $53.0 million or $0.60 per share, compared to a net loss of $38.9 million or $0.44 per share for the same period in 2002. Fourth quarter 2003 expenses included $9.3 million in costs related to starting up the company's antibody production facilities. The net loss for the fourth quarter of 2003 and 2002 included a $7.9 million and $2.2 million charge, respectively, associated with investments made in connection with collaborations.
Contract revenues for the fourth...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2004-03-26)
More Articles from Health Business Week
- Adherex Technologies, Inc.
Cancer therapeutics company reports loss of $0.03 per share - Advanced Medical Optics, Inc.
Ophthalmic device firm reports 13.5% increase in revenue - AlgoRx Pharmaceuticals, Inc.
Pain drug developer raises $65M in series C financing - AmSurg Corp.
Specialty surgery company reports fourth quarter earnings growth of 29% - Anika Therapeutics, Inc.
Bone, tissue repair company reports 17% increase in revenues - Anton Investments, Inc.
Nyer Medical Group closes subsidiary - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
